JY
TXG icon

Jeff Yass’s 10x Genomics TXG Stock Holding History

Jeff Yass’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Sell
86,421
-64,559
-43% -$1.69M ﹤0.01% 5420
2026
Q1 		$3.21M Buy
150,980
+97,452
+182% +$1.95M ﹤0.01% 5146
2025
Q4 		$873K Sell
53,528
-54,846
-51% -$829K ﹤0.01% 7488
2025
Q3 		$1.27M Sell
108,374
-95,435
-47% -$1.24M ﹤0.01% 6767
2025
Q2 		$2.36M Sell
203,809
-763,942
-79% -$6.96M ﹤0.01% 5439
2025
Q1 		$8.45M Buy
967,751
+879,491
+996% +$11.1M ﹤0.01% 2753
2024
Q4 		$1.27M Buy
88,260
+33,666
+62% +$531K ﹤0.01% 6389
2024
Q3 		$1.23M Sell
54,594
-36,487
-40% -$754K ﹤0.01% 6332
2024
Q2 		$1.77M Buy
91,081
+53,219
+141% +$1.39M ﹤0.01% 5329
2024
Q1 		$1.42M Sell
37,862
-14,192
-27% -$624K ﹤0.01% 6126
2023
Q4 		$2.91M Buy
52,054
+41,177
+379% +$1.79M ﹤0.01% 4632
2023
Q3 		$449K Buy
+10,877
New +$566K ﹤0.01% 8489
2023
Q2 		– Sell
-3,911
Closed -$212K – 13165
2023
Q1 		$218K Sell
3,911
-3,548
-48% -$166K ﹤0.01% 10412
2022
Q4 		$272K Sell
7,459
-73,518
-91% -$2.4M ﹤0.01% 9336
2022
Q3 		$2.31M Buy
80,977
+66,028
+442% +$2.52M ﹤0.01% 4630
2022
Q2 		$676K Buy
+14,949
New +$776K ﹤0.01% 7516
2022
Q1 		– Sell
-42,291
Closed -$3.7M – 14001
2021
Q4 		$6.3M Buy
42,291
+1,346
+3% +$206K ﹤0.01% 3370
2021
Q3 		$5.96M Buy
40,945
+25,956
+173% +$4.46M ﹤0.01% 3639
2021
Q2 		$2.94M Buy
14,989
+11,460
+325% +$2.07M ﹤0.01% 5071
2021
Q1 		$639K Sell
3,529
-34,615
-91% -$5.98M ﹤0.01% 8900
2020
Q4 		$5.4M Buy
+38,144
New +$5.54M ﹤0.01% 3299
2020
Q2 		– Sell
-24,833
Closed -$1.93M – 10958
2020
Q1 		$1.55M Buy
24,833
+20,404
+461% +$1.59M ﹤0.01% 4435
2019
Q4 		$338K Sell
4,429
-5,980
-57% -$360K ﹤0.01% 7794
2019
Q3 		$525K Buy
+10,409
New +$576K ﹤0.01% 7208

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jeff Yass's TXG Position: Q2 2026 in Review

Jeff Yass reduced its 10x Genomics (TXG) stake by 43% in Q2 2026, selling an estimated $1.69M and leaving 86,421 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5420.

Jeff Yass first reported a position in TXG in Q3 2019 and has held it in 24 quarters since. The position peaked at $8.45M in Q1 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Jeff Yass held 86,421 shares of 10x Genomics worth $3.31M as of Q2 2026.
  • Jeff Yass sold 64,559 10x Genomics shares in Q2 2026, an estimated $1.69M.
  • 10x Genomics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5420 holding.
  • Jeff Yass first reported a position in 10x Genomics in Q3 2019 and has held it in 24 quarters since.
  • Jeff Yass's 10x Genomics position peaked at $8.45M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.